Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

charges ($5.4 million, or $0.44 per share tax-effected), related to

the sale of the Company's endovascular business during the fourth

quarter of fiscal year 2008.

Note: To supplement our consolidated financial statements presented in

accordance with GAAP, Kensey Nash Corporation uses non-GAAP measures

of adjusted earnings per share, which are adjusted from our GAAP

results to exclude certain expenses. These non-GAAP adjustments are

provided to enhance the user's overall understanding of our

historical and current financial performance and our prospects for

the future. We believe the non-GAAP results provide useful

information to both management and investors by excluding certain

expenses that we believe are not indicative of our core operating

results.

These non-GAAP measures will provide investors and management with

an alternative method for assessing Kensey Nash's operating results

in a manner consistent with future presentation. Further, these

non-GAAP results are one of the primary indicators management uses

for planning and forecasting in future periods. The presentation of

this additional information should not be considered in isolation or

as a substitute for results prepared in accordance with accounting

principles generally accepted in the United States.

Supplemental Non-GAAP Financial Measures and Reconciliations

Kensey Nash Corporation

Non-GAAP Financial Measures and Reconciliations

Adjusted Income and Earnings Per Share Reconciliation

(Unaudited) (Unaudited)

As Reported Non-GAAP Adjustments As Adjusted

Three Emboli
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... , ... July 30, 2015 , ... The 2015 Market ... study on the current state of the global Propanol market with a focus on ... BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG ...
(Date:7/30/2015)... the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online ... contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... - New Product Under Development for the Treatment of ... Countries DAIICHI SANKYO EUROPE GmbH has applied in ... It is a fixed combination,(CS-8663) of two substances, the ... When approved, the new combination for treatment of ...
... Calif., Oct. 1 GenVault Corporation, the,leader in ... for Forensic Science will be presenting data showing ... storage media at room,temperature at the 18th International ... GenVault,s RPM storage media is a novel ...
... Advanced Instruments, Inc., (http://www.aicompanies.com ) today ... the biotechnology industry. The revolutionary high throughput,Multi-Sample ... 35 minutes. Designed to automate laboratory ... process optimization, the high throughput Multi-Sample 20G,Osmometer ...
Cached Biology Technology:DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin 2GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA 2Advanced Instruments Introduces World's Fastest High Throughput Freezing Point Osmometer 2Advanced Instruments Introduces World's Fastest High Throughput Freezing Point Osmometer 3
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/7/2015)... , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... on the growing mobile commerce market announces a revised version of ... week. The commercial will air on CNBC in New ... Angeles and San Francisco metro ... commercial focuses on Wocket,s ability to replace all the cards in ...
(Date:6/30/2015)... -- To bolster its efforts and commitment to fighting cyber ... addition of two new team members. ... David Raviv will act as head of strategic alliances. ... providing the most secure solutions for the enterprise market. ... Technologies, a provider of security and management products, which was ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... plant growth enhancers are becoming increasingly sought-after. Many ... with limited research capabilities, have not been tested ... effectiveness been documented by scientific data. Researchers from ... effect of Tea Seed Powder (TSP), a saponin-rich ...
... body are genetically identical, but develop into distinct cell types, ... some genes while inhibiting others. Remarkably, each specialized cell maintains ... should be kept on or off, even when making copies ... into the DNA, yet it is heritable. Instead, such non-genetic ...
... defense against predators or pathogens. Some are also used by ... medicines. As recently as the early 1990s, a unique class ... First noted through African tribal use as a tea ... been determined to serve as a powerful insecticidal and nematocidal ...
Cached Biology News:Plant growth affected by tea seed powder 2Making copies at the right time 2Making copies at the right time 3Cellular processing of proteins found in Congolese child birthing tea now revealed 2Cellular processing of proteins found in Congolese child birthing tea now revealed 3Cellular processing of proteins found in Congolese child birthing tea now revealed 4
Qa-1 (6A8.6F10)...
carnitine deficiency-associated gene expressed in ventricle 1...
HSV 1 IgG...
... Systems adds two new Stem Cell Antibody ... cell products. The Human Embryonic Stem Cell ... the antibodies against: alkaline phosphatase, Nanog, Oct-3/4, ... Cell Marker Antibody Panel Plus (Catalog # ...
Biology Products: